Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Coronado California 92118

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Fresno California 93720

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Pasadena California 91105

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Rialto California 92377

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

View More ▼

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Colorado

Western States Clinical Research, Inc.
Wheat Ridge Colorado 80033

The REGENERATE Study (Research Study for Treatment of NASH (Non-Alcoholic Steato-Hepatitis)/Advanced Fatty-Liver Disease)

View More ▼

Englewood Colorado 80113

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

District of Columbia

Washington District of Columbia 20037

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Florida

NEW

Gastro Florida
Clearwater Florida 33762

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NEW

Gastro Florida
Clearwater Florida 33762

A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of Ibat Inhibition With Multidose Measurement for Evaluation of Response).

NEW

Gastro Florida
Clearwater Florida 33762

AURORA: A Phase 3 Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis

Gastro Florida
Clearwater Florida 33762

TARGET-NASH: A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

Gastro Florida
Clearwater Florida 33762

TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

View More ▼

Miami Florida 33136

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Miami Florida 33136

A clinical trial to evaluate treatments using Tozadenant for patients with Hepatic Impairment

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Orlando Florida 32809-3017

A clinical trial to evaluate treatments using Tozadenant for patients with Hepatic Impairment

Tampa Florida 33612

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Wellington Florida 33414

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Magnetic Resonance Imaging (MRI) for patients with Non-alcoholic Fatty Liver Disease

Marietta Georgia 30060

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Kentucky

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Louisiana

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Shreveport Louisiana 71105

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Maryland

Baltimore Maryland 21202

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Catonsville Maryland 21228

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Massachusetts

Boston Massachusetts 02144

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Worcester Massachusetts 01605

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Michigan

Novi Michigan 48377

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Mississippi

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Missouri

Kansas City Missouri 64157

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

New Hampshire

Lebanon New Hampshire 03756

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

New York

Research Site
Additional Locations New York

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

View More ▼

Manhasset New York 11030

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

New York New York 10029

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

New York New York 10016

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Rochester New York 14642

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

North Carolina

Wake Research Associates
Raleigh North Carolina 27612

Do you have impaired liver function? Wake Research Associates is enrolling volunteers with liver impairment in a clinical research study testing an investigational medication for impaired liver function.

Wake Research Associates
Raleigh North Carolina 27612

Nonalcoholic Fatty Liver Disease (NAFLD)

Wake Research Associates
Raleigh North Carolina 27612

Non-alcoholic steatohepatitis (NASH)

Wake Research Associates
Raleigh North Carolina 27603

Nonalcoholic Steatohepatitis (NASH) with Bridging Fibrosis